Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Conjugate or complex
Reexamination Certificate
2006-03-28
2006-03-28
Devi, S. (Department: 1645)
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Conjugate or complex
C424S234100, C424S184100, C424S241100, C424S250100, C424S257100, C424S259100, C424S260100, C514S023000, C536S123100, C530S350000, C530S825000, C530S806000
Reexamination Certificate
active
07018636
ABSTRACT:
A vaccine, effective in inducing the production of antibodies with which to immunize a second subject passively against infection by Gram-negative bacteria and LPS-mediated pathology, comprises a non-covalent polyvalent complex formed between purified, detoxified LPS derived fromE. coliand purified outer membrane protein derived fromN. meningitidis. The same vaccine will also actively immunize a host subject against Gram-negative bacterial infections and LPS-mediated pathology. Meningococcal infections are included among those Gram-negative bacterial infections protected against by the vaccine.
REFERENCES:
patent: 4707543 (1987-11-01), Zollinger et al.
patent: 4918163 (1990-04-01), Young
patent: A-0 109 688 (1984-06-01), None
patent: WO 87/07148 (1987-12-01), None
patent: WO 91/01755 (1991-02-01), None
Teng et al. PNAS 82: 1790-1794, abstract, 1985.
Wickstrom et al. Vet. Microbiol. 13: 259-271, abstract, 1987.
Jachymek W. Postepy Hig Med. Dosw. 49: 171-178, abstract, 1995.
Tomita et al. J. Dairy Sci. 76: Suppl. 1: p. 159, abstract, 1993.
Spier et al. Circ. Shock. 28: 235-248, abstract, 1989.
Ziegler et al. Clin Res. 29: p. 576A, abstract, 1981.
Yoshioka et al. Res. Commun. Chem. Pathol. Pharmacol. 80: 367-370, abstract, 1993.
Tyler et al. Am. J. Vet. Res. 55: 1256-1260, abstract, 1994.
Tyler et al. J. Dairy Sci. 74: 1235-1242, 1991.
Tyler et al. J. Immunol. Methods 129: 221-226. 1990.
Tyler et al. Am. J. Vet. Res. 49: 1950-1954, 1988.
Pollack et al. J. Clin. Invest. 72: 1874-1881, 1983.
Ding et al. J. Med. Microbiol. 31: 95-102, 1990.
Nixdorff et al. In: Microbial Infections. (Eds) H. Friedman et al. Plenum Press, New York, 49-61, 1992.
Young et al. J. Clin Invest. 56: 850-861, 1975.
Ziegler et al. In: Seminars in Infectious Disease. (Eds) Weinstein et al. vol. IV, 366-369, 1982.
Liu et al. PNAS 89: 4633-4637, 1992.
Marks et al. J. Clin. Invest. 69: 742-749, 1982.
Cryz Jr. et al. Eur. J. Clin. Microbiol. 4: 180-185, 1985.
Moreno et al. Infect. Immun. 47: 527-533, 1985.
Cohen et al. Lancet 1: 8-10, 1987.
Hawe et al. In: Abstracts of papers presented in the Meeting on Modern Approaches to New Vaccines, Cold Spring Harbor Labortory, Sep. 16-20, 1992.
Lugowski et al. J. Immunol. Methods 95: 187-194, 1986.
Tyler et al. J. Dairy Sci. 75: 1821-1825, 1992.
Tomita GM. Immunization of dairy cows against coliform mastitis. Dissertation, The Ohio State University, 1985.
Tyler et al. J. Vet. Intern. Med. 4: 17-25, 1990.
McCullus et al. Infect. Immun. 55: 1042-1046, abstract, 1985.
Bhattacharjee et al. Infect. Dis. Clin. North Amer. 13: 355-369, Jun. 1999.
Schwartzer et al. J. Infect. Dis. 158: 1135-1136, 1985.
Cross et al, Infection & Immunity 61:2741-2747, 1993.
Colandru et al The Journal of Infectious Dis. 158: 312-319, 1988.
Mandrell et al, Infection & Immunity 57: 1590-1598 1989.
Moreno et al, Infection & Immunity 47:527-533 1985.
Cross et al Journal of Endotoxin Research 1994, pp. 57-69.
Greenman et al JAMA 266:1097-1102, 1991.
Moore te al. Translplantation 44: 249-253, 1987.
Dunn et al. Surgery 96: 440-446, 1984.
Braude et al J. Infect. Dis. 136: Suppl. S167-S173, 1997.
Ziegler et al. J. Immunol. 111: 433-438, 1973.
Campnagari et al. Microb. Pethogen. 8: 353-362, abstract, 1990.
Zollinger et al. J. Clin. Invest. 63: 836-848, 1979.
Salles et al. J. Infect. Dis. 159: 641-647, 1989.
Fenwick et al. Am. J. Vet. Res. 47: 1888-1891, abstract, 1986.
Fenwick et al. Infect. Immun. 53: 298-304, abstract, 1986.
Nelles et al. Infect. Immun. 46: 677-681, 1984.
Kanegasaki et al. In: Bacterial Endotoxin: Chemical, biological and clinical aspects. (Ed) Homma et al. Verlag Chemie, pp. 149-158, 1984.
Tomita Dissertation Abstracts International, vol. 56, abstract, 1994.
Said et al. J. Biol. Chem. 256: 7305-7310, abstract, 1981.
Gu et al. J. Clin. Microbiol. 30: 2047-2053, 1992.
Tomita et al. J. Dairy Sci. 78: 2178-2185, 1995.
Tomita et al. J. Dairy Sci. 78: 2745-2752, 1995.
Dale et al. J. Infect. Dis. 166: 316-325, 1992.
McCabe et al. Prog. Clin. Biol. Res. 47: 107-117, 1980.
Braude et al. J. Infect. Dis. 136: S167-A173, 1977.
Cryz et al. Eur. J. Clin. Microbiol. 4: 180-185, abstract, 1985.
Lugawski C. Acta Biochim. Pol. 42: 19-24, 1995.
Davis et al. J. Exp. Med. 147: 1007-1017, abstract, 1978.
Alan S. Cross. Annals of Int. Med. 121: 58-60, Jul. 1, 1994.
Bhattacharjee Apurba
Cross Alan
Sadoff Jerald
Zollinger Wendell
Arwine Elizabeth
Devi S.
Harris Charles H.
Moran John Francis
The United States of America as represented by the Secretary of
LandOfFree
Vaccine against Gram-negative bacterial infections does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Vaccine against Gram-negative bacterial infections, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Vaccine against Gram-negative bacterial infections will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3527872